wellrank.ai
Klarity logo

Klarity

First cited by AI Jun 13, 2026
klarity.health

Surfaced organically in AI answers about ozempic. Not yet profiled.

AI Visibility

Visibility trend

Ozempic, daily share of AI answers mentioning Klarity, through Jun 13, 2026.

16.7%

Avg position when mentioned: 3.0

By engine

Where Klarity is strong, and where it is invisible.

  • Perplexity
    66.7%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 1 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Klarity

PerplexityJun 13, 2026, 11:12 UTC
What are the best alternatives if I cannot get Ozempic, and who prescribes them online?

Based on current medical guidelines and available online services (as of 2026), here are the best alternatives to Ozempic (semaglutide) and information on which providers prescribe them online. Best Alternatives to Ozempic If you cannot access Ozempic, the most effective alternatives are other GLP-1 receptor agonists or dual GIP/GLP-1 agonists. These work similarly by regulating appetite and blood sugar. FDA-Approved Injectable Alternatives (Weight Loss) Wegovy (Semaglutide): The most direct alternative. It contains the exact same active ingredient as Ozempic but is FDA-approved specifically for chronic weight management. Dosage:* Starts at 0.25 mg/week, increasing to 2.4 mg/week. Zepbound (Tirzepatide): A newer, highly effective dual GIP/GLP-1 agonist. Clinical data often shows it leads to greater weight loss than semaglutide alone. Dosage:* Starts at 2.5 mg/week, increasing to 15 mg/week. Saxenda (Liraglutide): An older GLP-1 agonist approved for weight management (since 2014). It is effective but generally requires daily injections rather than weekly. Note:* An authorized generic of liraglutide (active ingredient in Saxenda/Victoza) is now available, potentially lowering costs. FDA-Approved Oral Alternative Rybelsus (Semaglutide): The first oral GLP-1 medication. It contains the same active ingredient as Ozempic and Wegovy. Use:* Primarily FDA-approved for Type 2 diabetes but often prescribed for weight loss. Benefit:* Ideal for patients who dislike needles. Other Prescription Options (Non-GLP-1) If GLP-1s are not accessible or suitable, doctors may prescribe: Contrave (Naltrexone-Bupropion): Combines two drugs to affect brain appetite/reward centers. Orlistat (Xenical/Alli): Blocks fat absorption. (Xenical is prescription; Alli is OTC). Phentermine (Adipex/Suprenza): A short-term stimulant for appetite suppression. Metformin: Often used for Type 2 diabetes; sometimes prescribed off-label for weight management (less effective than GLP-1s). Who Prescribes Them Online? Several reputable telehealth platforms specialize in weight loss and can evaluate you via video or questionnaire to prescribe these medications. Important Note: Legitimate providers will not prescribe these medications without a review of your medical history, and they often require a recent blood test (which can be done at a local lab like Quest or LabCorp) to ensure safety. Top Telehealth Providers for Weight Loss: Ro (formerly Ross Health): What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Dedicated "Go" program for weight loss; offers medication management and coaching. Hims & Hers Health: What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Integrates medication with lifestyle coaching; very popular for online prescriptions. Klarity (Klarity Health): What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Focuses on connecting patients with local doctors for telehealth visits. Wellness Wanderer (or similar specialized clinics): Many specialized obesity medicine clinics (like Obesity Medicine Association members) offer remote consultations. NovoCare Pharmacy & LillyDirect: Note: These are manufacturer programs, not prescribers. If you have a prescription from any* doctor (online or in-person), you can use these services to get Wegovy or Zepbound shipped directly, often at a lower cash price (e.g., $650 for Wegovy, $399–$650 for Zepbound). How to Get Prescribed Online: Sign Up: Choose a provider (e.g., Ro, Hims, Hers). Medical Review: Complete a health questionnaire and undergo a telehealth video consultation with a licensed provider (MD, DO, or NP). Lab Work: The provider may order a blood test (AST/ALT, kidney function, etc.) to be done at a local lab. Prescription: If approved, the medication is shipped to your home or sent to a local pharmacy for pickup. Monitoring: You will need ongoing monthly or quarterly check-ins to monitor progress and adjust dosages. Cost Considerations & Compounding Savings Coupons: Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) offer savings programs for cash-paying patients without insurance coverage for obesity drugs. Compounded Medications: Some telehealth providers offer compounded versions of semaglutide or tirzepatide as a cheaper alternative. However, the FDA has issued warnings about compounded GLP-1s regarding safety and purity. Always verify the provider's accreditation. Authorized Generics: If you switch to Saxenda, ask your doctor about the authorized generic liraglutide, which is significantly cheaper than the branded version. Summary Recommendation If you want the closest alternative with the same efficacy, Wegovy is the top choice. If you want the highest potential for weight loss, Zepbound is the best option. If you refuse injections, Rybelsus is your go-to. For online prescribing, Ro, Hims & Hers, and Klarity are the most established and reliable platforms for these specific medications in 2026. Always consult with a healthcare professional to ensure these medications are safe for your specific health profile.

Mentioned in position 3 of 10

Read full answer with sources →
PerplexityJun 13, 2026, 11:11 UTC
Which online Ozempic providers handle prior authorization with insurance?

Based on current information, several online telehealth providers offer Ozempic prescriptions and assist with the prior authorization (PA) process with insurance companies. However, it is important to note that Ozempic is FDA-approved only for Type 2 Diabetes, not for weight loss, which significantly impacts insurance coverage eligibility. Here are the key online providers that handle prior authorization: PlushCare PA Handling: PlushCare states that their physicians and care team will reach out to your insurer on your behalf to handle the prior authorization request. Note: They emphasize that a Type 2 Diabetes diagnosis is required for insurance approval. The process can take several business days. Cost: They offer virtual visits with insurance (often $30 or less for in-network) or cash pay ($129 for initial visits). Ro (Ro Body) PA Handling: Ro offers an insurance concierge service. Their concierge "fights for coverage," submits all paperwork, and works with the insurance provider to determine coverage for GLP-1 medications. Note: Ro explicitly states Ozempic is not FDA-approved for weight loss. They may prescribe it off-label. Their insurance concierge is separate from the Ro Body membership fee (which is cash-only). Limitation: They currently cannot coordinate coverage for GLP-1s for government insurance plans (e.g., Medicare), though they may assist with private plans. Plastic & Ro (General Telehealth) Many other telehealth platforms (like Ro, PlushCare, Klarity, and HelloKlarity) can* initiate the prescription, but their ability to secure insurance coverage depends entirely on the patient meeting the PA criteria (Type 2 Diabetes). Klarity Health / HelloKlarity: These platforms often focus on weight loss. While they can evaluate weight loss needs, they frequently inform patients that insurance coverage for weight loss is unlikely without a diabetes diagnosis, and they may not have a dedicated "concierge" team to fight for PA in the same way Ro does. CoverMyMeds & Spry (Technology Partners, Not Providers) It is worth noting that many providers use third-party platforms like CoverMyMeds or Spry to automate and submit prior authorization requests electronically. These tools streamline the process for providers but are not the direct patient-facing "providers" themselves. Critical Considerations for Prior Authorization: Diagnosis Requirement: Almost all insurance companies will deny prior authorization for Ozempic if the patient only has a weight loss diagnosis. A Type 2 Diabetes diagnosis is typically mandatory for coverage. Weight Loss vs. Diabetes: If you are seeking Ozempic strictly for weight loss, you may face auto-denials from insurance regardless of the provider. You may need to pay the full cash price (approx. $949/month) or use a savings offer (e.g., from NovoCare). Appeals: If a PA is denied, providers like Ro and PlushCare can assist in filing an appeal or initiating a peer-to-peer review with the insurer. Recommendation: If you have Type 2 Diabetes, PlushCare and Ro are the most robust options for handling PA actively. If you are seeking Ozempic only for weight loss, be prepared that most insurance plans will deny coverage regardless of the provider, and you should verify cash prices or savings programs beforehand.

Mentioned in position 3 of 7

Read full answer with sources →

Public AI visibility history

Daily rank of Klarity on our buyer intent questions, per category. A dash means the engines did not cite Klarity at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Ozempic#14

TL;DR

Klarity (klarity.health) is a telehealth platform that connects patients with licensed clinicians for online evaluations and treatment, with a notable presence in weight management and GLP-1 related care. It currently ranks fifth in WellRank's Ozempic AI-answer index with 17% visibility, meaning it surfaces in roughly one in six AI-generated responses about Ozempic, placing it alongside major players such as Ro and PlushCare. Its two indexed AI mentions skew positive-to-neutral, a solid early signal for a brand that has not yet been formally profiled by the index.

Company Overview

Klarity operates as an asynchronous and on-demand telehealth service, allowing patients to complete online assessments and receive clinician-reviewed care plans without scheduling a traditional appointment. The platform covers multiple condition areas and connects users to prescribers who can order treatments or refer them for further care. Founding details and headquarters are not publicly disclosed in widely available sources. Its business model is primarily direct-to-consumer, with patients paying out of pocket or using insurance depending on the service.

Product Features

  • Online clinician evaluations for weight management and GLP-1 medication access
  • Prior authorization support for GLP-1 prescriptions, as detailed at https://www.helloklarity.com/post/ozempic-prior-authorization-criteria/
  • Asynchronous care model allowing patients to complete assessments on their own schedule
  • Multi-condition telehealth coverage beyond weight loss
  • Prescription coordination and follow-up care through the platform

Target Market

Klarity primarily serves adult patients in the United States seeking convenient access to telehealth evaluations, with a growing focus on individuals pursuing GLP-1 weight-loss medications such as Ozempic. It is relevant to patients who face prior authorization hurdles or who want a digital-first alternative to in-person obesity medicine visits. Geographic reach appears to span multiple U.S. states, though full state availability is not publicly confirmed.

Buyer Personas

  • An adult with overweight or obesity who wants a fast online pathway to a GLP-1 evaluation without waiting months for an in-person specialist.
  • A patient who has received a GLP-1 prescription but needs help navigating prior authorization with their insurer.
  • A cost-conscious consumer researching cheaper alternatives to Ozempic and comparing telehealth platforms before committing.
  • A primary care patient in a region with limited obesity medicine specialists who turns to telehealth for convenient ongoing weight-management support.

Funding & Performance

Funding stage, total capital raised, and valuation are not publicly disclosed. The company appears to operate as a private venture; no IPO or major public funding announcement is widely documented.

Recent Developments

Klarity has expanded its content and clinical focus around GLP-1 medications, including educational resources on prior authorization processes that have been cited by AI engines, as seen at its prior authorization guide. The brand is beginning to appear in third-party roundups covering Ozempic alternatives and GLP-1 access, signaling growing organic visibility in a competitive category. Specific product launch dates are not publicly confirmed.

Competitive Landscape

WellRank's co-mention data shows Klarity appearing in AI answers alongside Ro, PlushCare, Spry, Quest, the Obesity Medicine Association, and Novo Nordisk's NovoCare programs. Ro and PlushCare are its most direct telehealth competitors, both offering GLP-1 prescribing pathways with larger public brand footprints. Klarity differentiates partly through its asynchronous model and prior authorization guidance, but competes in a crowded field where brand recognition and insurance partnerships matter significantly.

Klarity vs the brands AI recommends alongside it

The real competitive set in Ozempic: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Klarity logo
KlarityThis brand
#14
16.7%
Ro logo
Ro

2 shared answers

#2
58.3%
CoverMyMeds logo
CoverMyMeds

1 shared answers

#44
8.3%
Eli Lilly logo
Eli Lilly

1 shared answers

#22
8.3%
HelloKlarity logo
HelloKlarity

1 shared answers

#47
8.3%

Email me when overtakes Klarity

One email the day the ranks flip. Nothing else.

User Sentiment

Of the two AI-engine mentions tracked by WellRank, one is positive and one is neutral, with no cautious or mixed signals recorded, suggesting that when AI assistants mention Klarity they do so in a favorable or matter-of-fact context. Broader public sentiment is difficult to assess given limited large-scale review data in widely available sources. The brand's presence in credible third-party content, including coverage at Verywell Health and GoodRx, indicates a growing but still early reputation in the GLP-1 telehealth space.

Pricing

Pricing is not publicly published in a stable, widely verifiable form. As a direct-to-consumer telehealth service, costs likely vary by condition, state, and whether insurance is applied; prospective patients should consult klarity.health directly for current pricing.

Sources cited around Klarity

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Klarity weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Klarity? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.

Klarity: AI visibility report | WellRank